INDP logo

Indaptus Therapeutics (INDP)

Profile

Full Name

Indaptus Therapeutics, Inc.

Ticker Symbol

INDP

Exchange

NASDAQ

Country

United States

IPO

August 4, 2015

Indexes

Not included

Employees

7

Key Details

Price

$0.48(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.61(+12.02% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Nov 13, 24 Maxim Group
Buy
Oct 16, 24 HC Wainwright & Co.
Buy
Jun 17, 24 HC Wainwright & Co.
Buy
Apr 15, 24 HC Wainwright & Co.
Buy
Sep 20, 23 HC Wainwright & Co.
Buy
Aug 15, 23 HC Wainwright & Co.
Buy
Aug 11, 23 HC Wainwright & Co.
Buy
Aug 8, 23 HC Wainwright & Co.
Buy
May 4, 23 HC Wainwright & Co.
Buy
Mar 20, 23 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Indaptus Therapeutics?
  • Does Indaptus Therapeutics pay dividends?
  • What sector is Indaptus Therapeutics in?
  • What industry is Indaptus Therapeutics in?
  • What country is Indaptus Therapeutics based in?
  • When did Indaptus Therapeutics go public?
  • Is Indaptus Therapeutics in the S&P 500?
  • Is Indaptus Therapeutics in the NASDAQ 100?
  • Is Indaptus Therapeutics in the Dow Jones?
  • When was Indaptus Therapeutics's last earnings report?
  • When does Indaptus Therapeutics report earnings?
  • Should I buy Indaptus Therapeutics stock now?

What is the ticker symbol for Indaptus Therapeutics?

The ticker symbol for Indaptus Therapeutics is NASDAQ:INDP

Does Indaptus Therapeutics pay dividends?

No, Indaptus Therapeutics does not pay dividends

What sector is Indaptus Therapeutics in?

Indaptus Therapeutics is in the Healthcare sector

What industry is Indaptus Therapeutics in?

Indaptus Therapeutics is in the Biotechnology industry

What country is Indaptus Therapeutics based in?

Indaptus Therapeutics is headquartered in United States

When did Indaptus Therapeutics go public?

Indaptus Therapeutics's initial public offering (IPO) was on August 4, 2015

Is Indaptus Therapeutics in the S&P 500?

No, Indaptus Therapeutics is not included in the S&P 500 index

Is Indaptus Therapeutics in the NASDAQ 100?

No, Indaptus Therapeutics is not included in the NASDAQ 100 index

Is Indaptus Therapeutics in the Dow Jones?

No, Indaptus Therapeutics is not included in the Dow Jones index

When was Indaptus Therapeutics's last earnings report?

Indaptus Therapeutics's most recent earnings report was on Mar 13, 2025

When does Indaptus Therapeutics report earnings?

The next expected earnings date for Indaptus Therapeutics is May 8, 2025

Should I buy Indaptus Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page